Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report

Small cell lung cancer (SCLC) transformation is a rare resistance mechanism to anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs), for which cytotoxic chemotherapy is often initiated. However, no case has been reported so far in which the SCLC component disappeared after chemotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamagata, Akira, Yokoyama, Toshihide, Fukuda, Yasushi, Ishida, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349051/
https://www.ncbi.nlm.nih.gov/pubmed/34401280
http://dx.doi.org/10.1016/j.rmcr.2021.101440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349051/
https://www.ncbi.nlm.nih.gov/pubmed/34401280
http://dx.doi.org/10.1016/j.rmcr.2021.101440

Ejemplares similares